Doravirine and the Potential for CYP3A-Mediated Drug–Drug Interactions
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02016-18
Full Text
Open PDFAbstract
Available in full text
Date
February 19, 2019
Authors
Publisher
American Society for Microbiology